Close-Up International Welcomes Jim Barone as Executive VP

Close-Up International Strengthens Leadership with New Appointment
Close-Up International, a prominent provider of customer relationship management (CRM) and data technology solutions tailored to the life sciences sector, has made a significant move in its executive team by appointing Jim Barone as the Executive Vice President of Business Solutions. This strategic appointment is aimed at propelling Close-Up's expansion into the U.S. CRM market and fostering growth initiatives that align with the ever-evolving demands of the life sciences industry.
Experience that Matters
With more than 30 years of experience within the life sciences arena, Jim Barone brings a wealth of knowledge and a rich background in pharmaceuticals, data analytics, and emerging technologies to Close-Up. His career has been marked by a commitment to innovation, particularly in CRM strategies and advanced analytics solutions.
Before joining Close-Up International, Jim held influential leadership positions, such as the Senior Director of Product Strategy at Veeva Systems and Area VP of Sales at Komodo Health. In these roles, he spearheaded various initiatives focusing on aligning CRM product development to meet the needs of major accounts and successfully launching market access platforms tailored for both emerging and mid-sized pharma companies.
A Leader with a Vision
Jim's exemplary career includes over 15 years as President and CEO of BusinessOne Technologies, where he led teams in the creation, development, and deployment of data-driven CRM platforms. His leadership resulted in scalable solutions that have had a lasting impact on the pharmaceutical industry.
Robert Thomas, Chief Commercial Officer (CCO) at Close-Up, remarked, "Jim's extensive experience and deep industry insight will play a critical role as we elevate our CRM capabilities in the U.S. market, delivering top-tier solutions to our pharmaceutical clients. With the disruption in the CRM landscape caused by competitors like Salesforce and Veeva, there's a significant opportunity for us to offer proven AI-powered CRM solutions, having already established strong relationships with over 245 active CRM clients across 50 countries."
Excitement for the Future
Expressing enthusiasm about joining Close-Up, Jim Barone stated, "I am thrilled to step into this role during such a transformative period for our industry. Close-Up possesses a truly remarkable CRM platform, recognized as the only 5-star peer-reviewed pharma CRM solution in Gartner for 2025. I am eager to collaborate with the team, enhancing our offerings and supporting our clients in achieving commercial success." This appointment signifies Close-Up's ongoing commitment to innovation, client success, and an ambitious approach towards growth in the U.S. pharmaceutical CRM landscape.
About Close-Up International
Close-Up International is a leading provider of AI-enhanced CRM, data analytics, and business intelligence solutions within the global life sciences sector. With an impressive track record spanning more than 55 years, Close-Up services over 650 healthcare clients in 50+ countries, boasting more than 47,000 active users of its CRM solutions. Positioned among the top three global providers of pharmaceutical CRM, Close-Up's AI-driven platform significantly enhances client engagement with healthcare professionals by identifying real-time opportunities and challenges while increasing overall productivity.
The platform is designed for streamlined adoption, featuring an easy-to-use interface, flexible data integration capabilities, and long-term cost advantages for pharmaceutical companies.
For further details or inquiries, please contact us via:
Email: info@closeupus.com
Contact: Robert Thomas | Close-Up International
Frequently Asked Questions
What is the significance of Jim Barone’s appointment?
Jim Barone's appointment as Executive VP is crucial for leading Close-Up's strategic growth initiatives within the U.S. CRM market.
What experiences does Jim Barone bring to Close-Up International?
Jim has over 30 years in life sciences, previously serving in leadership roles at notable companies like Veeva Systems and BusinessOne Technologies.
How does Close-Up International stand out in the pharmaceutical CRM industry?
Close-Up offers an AI-driven CRM solution recognized as a top 5-star peer-reviewed platform, emphasizing innovation and client success.
What opportunities exist in the U.S. CRM market?
With recent disruptions by competitors, there is a significant opportunity to offer advanced AI-based CRM solutions to pharmaceutical companies.
How does Close-Up ensure successful client engagement?
Close-Up utilizes real-time analytics and a user-friendly platform to enhance client interactions and identify market opportunities.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.